ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?
Advanced RET-rearranged NSCLC
Update on olaparib in ovarian cancer
CPX-351 improves outcomes for refractory AML
Radiotherapy modalities for locally advanced non-small cell lung cancer
Large disparities found in BCRA testing across ethnicities
Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer
ASCO 2016: Plenary Session Review
Elderly patients with glioblastoma live longer with chemoradiation using temozolomide
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery
Primary tumour location in metastatic colorectal cancer impacts overall survival
Novel antibody helps patients with advanced gastric cancer live longer